Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Publication Frequency

International Journal of Drug Regulatory Affairs (IJDRA) has Publication frequency Quarterly (4 issue/year). We always publish every issue timely since starting of this journal. Issue schedule is 15-March, 15-June, 15-September and 15-December in every year for issue 1, 2, 3, and 4 respectively.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Archiving Policy

This journal utilizes the RoMEO & Copernicus Index to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.

This Journal works on OJS/PKP platform and provides interface for metadata harvesting and XML for Articles & Issues.

Policy Statement – Human and Animal Rights

Any investigations involving humans and animals should be approved by the Institutional Review Board and Animal Care Committee, respectively, of the institution where the study took place. International Journal of Drug Regulatory Affairs (IJDRA) will not consider any studies involving humans or animals without the appropriate approval. If no formal ethics committee is available, the authors should indicate whether the procedures were compliant with the Helsinki Declaration as revised in 2008. Informed consent should be obtained, unless waived by the Institutional Review Board, from patients who participated in clinical investigations. Human subjects should not be identifiable, such that patients' names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. If experiments involve animals, the research should be based on national or institutional guidelines for animal care and use. Original articles submitted to International Journal of Drug Regulatory Affairs (IJDRA) that address any investigation involving humans and animals should include a description about whether the study was conducted under an approval by the Institutional Review Board (with or without patient informed consent) and animal care committee, respectively, of the institution where the study was conducted.

Policy Statement – Conflict of Interest

All Authors publishing in International Journal of Drug Regulatory Affairs (IJDRA) must declare all financial disclosures and conflicts of interest in the article file of manuscripts submitted for publication.

For more information on Conflict of Interest, see the guidelines from the ICMJE.

Policy Statement – Informed Consent

All human studies submitted for publication in International Journal of Drug Regulatory Affairs (IJDRA) require informed consent and ethics committee approval. If waiver of consent was granted by the ethics committee in the case of retrospective studies not impacting on patient confidentiality or patient rights, this must be clearly stated in the cover letter and manuscript.

Plagiarism Policy

The International Journal of Drug Regulatory Affairs (IJDRA) is dedicated to publishing only original material. The journal staff has a policy of screening for plagiarism. All articles in this publication are original: the content (either in full or in part) in each article has not been knowingly republished without specific citation to the original release. Plagiarism checker is applied randomly to the majority of the papers submitted.

If any manuscript is found to be plagiarized, immediate action will be taken, which will include and not limited to the following:

  1. Retraction of paper in question, from online system, review, and from all other processing.
  2. Black listing of concerned author(s) in question.
  3. Rejection of all other manuscripts submitted by the author(s) in question.
  4. Reporting of the issue to the concerned authorities, including the authors' institution.

Note: IJDRA encourages the submission of original articles by authors. Acts of plagiarism will not be condoled by the journals. Submitted work if discovered to be plagiarized will be withdrawn from the journal's website and legal action may be taken against such author if deemed necessary.

We use "VIPER Anti-Plagiarism Scanner" to detect the Plagiarism in the text. Viper is a program that will scan for Plagiarism in any text.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.